healthcare

healthcare Articles

The November 30 short interest data have been compared with the previous figures, and short interest in most of these selected pharmaceutical stocks increased.
The November 30 short interest data have been compared with the previous report, and short interest moves in the selected biotech stocks were mixed.
It is not unusual for people to eat raw cookie dough as they make the cookies. The habit should be avoided, according to the CDC.
Ra Pharmaceuticals shares jumped on Monday after the company announced positive mid-stage results for the treatment of generalized myasthenia gravis.
Marinus Pharmaceuticals shares made a handy gain on Monday after the company announced positive results from its midstage trial in women with postpartum depression.
Gilead shares made a slight gain early on Monday after the firm announced that there would be a big change at the top, in terms of its senior management. Not to mention, this executive is coming from...
24/7 Wall St. takes a look at what is coming up in the FDA calendar regarding biotech and pharmaceutical companies expecting updates to their drug pipeline or other major events for the rest of 2018.
Moderna entered the market quietly on Friday after it priced what is being called the biggest biotech IPO to date.
GBT shares dipped on Friday after the company announced that it would be conducting a secondary offering. This offering comes on the heels of a key FDA approval.
Supernus Pharmaceuticals shares dipped on Thursday despite the firm posted positive results from two of its late-stage studies in children for the treatment of attention deficit hyperactivity...
Conatus Pharmaceuticals shares were more than halved on Thursday after the company announced top-line results from its midstage trial in cirrhosis patients.
Clovis Oncology shares jumped on Tuesday after the European Patent Office upheld the company’s claims.
Global Blood Therapeutics shares shot up on Monday after the company announced that it received an update from the FDA in regards to its sickle cell disease treatment.
Vanda Pharmaceuticals shares made a solid gain on Monday after the firm announced results from a midstage trial of patients with idiopathic and diabetic gastroparesis.
Tesaro shares absolutely exploded early on Monday after the company announced that it has entered a definitive agreement to be acquired by GlaxoSmithKline.